MedPath

Cognitive Behavioral Therapy for Insomnia in Type 2 Diabetes Mellitus

Not Applicable
Recruiting
Conditions
Type 2 Diabetes
Insomnia
Interventions
Behavioral: cognitive behavioral therapy for insomnia
Behavioral: Health education
Registration Number
NCT06202742
Lead Sponsor
Mahidol University
Brief Summary

This study will explore the effects of cognitive behavioral therapy for insomnia (CBTI) compare to health educations in patients with type 2 diabetes (T2DM) with insomnia symptoms.

Detailed Description

This study will recruit participants with T2DM with insomnia symptoms and randomize them to weekly CBTI or health education for 8 weeks. Outcomes will be measured at baseline and 8 week, and 16 weeks (8 weeks post intervention).

Primary outcome will be subjective sleep quality as assessed by Pittsburgh Sleep Quality Index Secondary outcomes will be fasting glucose, hemoglobin A1C, insulin levels, high sensitivity c-reactive protein, objective sleep parameters from accelerometer, depressive symptoms, daytime sleepiness, quality of life, anxiety symptoms and stress symptoms.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Type 2 diabetes mellitus age 30 to 65 years old
  • Hemoglobin A1C ≥ 6.5 but ≤ 10 %
  • Have poor sleep quality as assessed by Insomnia Severity Index ≥ 15
  • Receive the same hypoglycemic treatments 3 months before the intervention
  • If using sleep aid, the dose needs to be stable for 3 months prior to the enrollment
  • Ability to use the electronic devices (computer, tablet) and assess the internet
  • Willing to attend all of the 8 sessions activities
Exclusion Criteria
  • Type 1 diabetes mellitus
  • Night shift work
  • Insulin therapy
  • Severe hypoglycemia who required hospitalization or emergency department visit in the past 6 months
  • History of diabetic ketoacidosis in the past 6 months
  • Medically unstable conditions eg. renal replacement therapy, liver failure, heart failure, active cancer, epilepsy, unstable cerebrovascular disease
  • Psychosis, uncontrolled depression
  • Untreated obstructive sleep apnea or STOP-BANG ≥ 5
  • Language/communication/hearing/sight disability
  • Pregnancy or lactation
  • Care giver of infant
  • Harmful alcohol/smoking (≥15 standard-drink in men and ≥8 standard-drink in women)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive behavioral therapycognitive behavioral therapy for insomniaCognitive behavioral therapy for insomnia (CBTI) is non-medical treatment to improve insomnia. CBTI group will attend online meeting, 1 hour weekly for 8 weeks.
Health educationHealth educationHealth education group will attend online meeting, 1 hour weekly for 8 weeks.
Primary Outcome Measures
NameTimeMethod
Subjective Sleep Quality16 weeks

Subjective Sleep Quality as assessed by Pittsburgh Sleep Quality Index

Secondary Outcome Measures
NameTimeMethod
High sensitivity c-reactive protein8 weeks

serum sample for Hs-CRP

Metabolic parameters8 weeks

Fasting glucose and insulin, hemoglobin A1C

Patient reported outcomes16 weeks

Questionnaires to assess depressive symptoms, stress, anxiety, daytime sleepiness, and quality of life

Objective sleep parameters8 weeks

Sleep will be obtained using 1-week accelerometer recording

Trial Locations

Locations (1)

Faculty of Medicine Ramathibodi Hospital Mahidol University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath